{"article_title": "PhRMA Launches New Suit Over 340B Orphan Drug Rule", "article_keywords": ["340b", "drugs", "launches", "view", "orphan", "phrma", "rule", "withhold", "used", "drug", "suit", "theyre", "targets", "york"], "article_url": "http://www.law360.com/articles/585973/phrma-launches-new-suit-over-340b-orphan-drug-rule", "article_text": "PhRMA Launches New Suit Over 340B Orphan Drug Rule\n\nLaw360, New York (October 9, 2014, 7:07 PM ET) -- Reviving a high-stakes fight, Pharmaceutical Research and Manufacturers of America on Thursday sued the U.S. Department of Health and Human Services in D.C. federal court to prevent regulators from disciplining drugmakers that sometimes withhold discounts on so-called orphan drugs in the 340B program.\n\n\n\nPhRMA\u2019s complaint targets an HHS rule that says orphan drugs should be discounted under 340B when they\u2019re not being used for rare diseases. That policy was issued in July and described as an \u201cinterpretive rule\u201d that describes the agency\u2019s reading of an Affordable...\n\nTo view the full article, register now.", "article_metadata": {"description": "Reviving a high-stakes fight, Pharmaceutical Research and Manufacturers of America on Thursday sued the U.S. Department of Health and Human Services in D.C. federal court to prevent regulators from disciplining drugmakers that sometimes withhold discounts on so-called orphan drugs in the 340B program.", "apple-itunes-app": "app-id=934560389, app-argument=law360://www.law360.com/articles/585973/phrma-launches-new-suit-over-340b-orphan-drug-rule", "csrf-token": "Pyc8LbJR2LX0sILLV1GMRQej2WWLjiGfAQF7+5CQqAVm8OhqAcX7ig5D3zeAQl00JnKMcfl2gi7PX1rd8EXMXQ==", "csrf-param": "authenticity_token", "og": {"url": "http://www.law360.com/articles/585973/phrma-launches-new-suit-over-340b-orphan-drug-rule", "image": "https://www.law360.com/images/360.png", "type": "website", "title": "PhRMA Launches New Suit Over 340B Orphan Drug Rule - Law360"}, "viewport": "width=device-width, initial-scale=1.0"}, "article_summary": "PhRMA\u2019s complaint targets an HHS rule that says orphan drugs should be discounted under 340B when they\u2019re not being used for rare diseases.\nPhRMA Launches New Suit Over 340B Orphan Drug RuleLaw360, New York (October 9, 2014, 7:07 PM ET) -- Reviving a high-stakes fight, Pharmaceutical Research and Manufacturers of America on Thursday sued the U.S. Department of Health and Human Services in D.C. federal court to prevent regulators from disciplining drugmakers that sometimes withhold discounts on so-called orphan drugs in the 340B program.\nThat policy was issued in July and described as an \u201cinterpretive rule\u201d that describes the agency\u2019s reading of an Affordable...To view the full article, register now."}